New CDC antimicrobial resistance updates show why antibiotic overuse in clinics and urgent care still threatens patient safety. Here’s what resistant infections mean for everyday Americans—and how to reduce your risk.
If you’re 32–36 weeks pregnant during RSV season, a one-time RSV vaccine may help protect your newborn during the highest-risk months. Here’s how it works, how it compares with infant nirsevimab, what the trial data show, and what to consider for the 2025–2026 season.
New FDA-approved obesity medications have changed treatment options—but Medicare’s long-standing drug coverage rules still shape who can access them. Here’s what adults and families should understand in 2026 about eligibility, costs, and policy limits.
Ultra-processed foods are often blamed for rising rates of heart disease and diabetes. Here’s what the U.S. Dietary Guidelines and major studies actually show—what’s known, what’s uncertain, and what practical steps families can take.
FDA-approved anti-amyloid drugs such as lecanemab are now in real-world use for early Alzheimer’s disease. Here’s who qualifies, what the main clinical trial showed, what ARIA risks mean, and how Medicare coverage works in the United States.
FDA traditional approval of lecanemab for early Alzheimer’s disease offers modest slowing of decline for some patients—but requires careful screening, MRI monitoring, and meeting Medicare coverage rules. Here’s what families should understand in 2026.
The newest CDC provisional suicide data show a slight shift after recent record highs. Here’s what the numbers mean, who is most affected, and how the 988 Suicide & Crisis Lifeline is functioning for families in 2026.
CMS has finalized the 2026 Medicare Physician Fee Schedule, updating how doctors are paid, refining telehealth rules, and adjusting quality programs. Here’s what those changes could mean for appointment access, costs, and care coordination.
Medical words can feel intimidating—especially in lab portals, discharge summaries, and health news. Here’s how understanding terms like “positive test,” “benign,” “acute,” and “randomized controlled trial” can help you make safer, more informed health decisions.
CDC surveillance data from early 2026 show an uptick in U.S. measles cases, with outbreaks concentrated in under-vaccinated communities. Here’s what the latest numbers mean, who is most at risk, and how families can protect themselves.
The CDC’s interim 2025–2026 flu vaccine effectiveness estimates show moderate protection against medically attended influenza this season. Here’s what the numbers mean, how they’re calculated, and why vaccination and early treatment still matter.
H5N1 avian influenza has spread from poultry into U.S. dairy cattle, with a small number of human cases linked to farm exposure. Here’s what investigators know about transmission, milk safety, and what families should understand in 2026.
In 2026, Medicare beneficiaries are seeing the first real-world effects of negotiated drug prices and a new $2,000 annual out-of-pocket cap under Part D. Here’s what changed, which drugs are affected, and what to check with your plan.
The March 2026 MACPAC Report to Congress reviews Medicaid and CHIP enrollment after the COVID-19 unwinding, access to care challenges, managed care oversight, and federal–state financing pressures. Here’s what families should know.
The CDC’s latest provisional data show that maternal deaths in the United States remain a serious public health concern. Here’s what the newest numbers mean for pregnant and postpartum families, including leading causes, disparities, warning signs, and why insurance coverage after birth matters.
Federal rules now require hospitals and health plans to publish pricing data and cost-sharing tools. Here’s what that means for patients—and how physician practices can communicate costs clearly without overpromising.
The CDC’s 2026 Adult Immunization Schedule includes specific guidance for adults who are immunocompromised, including many people living with lupus. Here’s what it means for influenza, COVID-19, pneumococcal, RSV, and shingles vaccines — and how medication timing and insurance coverage come into play.
Leg pain with walking that improves with rest can be a sign of peripheral artery disease (PAD), a common and underdiagnosed condition linked to heart attack and stroke risk. Here’s what U.S. readers should know about symptoms, diagnosis, treatment, and when to seek urgent care.
CDC data show renewed measles clusters in under-vaccinated U.S. communities in 2025–2026. Here’s what families need to know about symptoms, school exposures, MMR protection, and what to do after contact.
The CDC’s 2026 immunization schedules reflect updated ACIP recommendations for children, teens, and adults. Here’s what changed, who may be newly eligible, and how those recommendations affect insurance coverage under the ACA, Medicare Part D, Medicaid, and the Vaccines for Children program.
The CDC’s 2025–2026 COVID-19 vaccine guidance focuses on updated formulations designed to match circulating variants and protect against severe disease. Here’s what the recommendations mean for your immune system, who should get additional doses, and what the latest effectiveness data show.
Severe low blood sugar remains a preventable but dangerous complication of diabetes. Updated 2026 guidelines from the American Diabetes Association emphasize broader continuous glucose monitoring, safer medication choices, and ready-to-use glucagon — with important insurance implications for older adults.
End of content
End of content
